§ Lord Morris of Manchester
asked Her Majesty's Government:
How many recorded incidents of infection there have been (a) among children under 16 with haemophilia since recombinant treatment was introduced for them in 1998; and (b) among adults with haemophilia using plasma-derived products since the same date. [HL3414]
§ Lord Hunt of Kings Heath
Since 1998 the Medicines Control Agency has received no reports of infections associated with recombinant treatment among children under 16 with haemophilia and no reports of infections in adults receiving plasma derived products for the treatment of haemophilia. Reports of suspected adverse drug reactions are made voluntarily by doctors, dentists, pharmacists and coroners.